Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

12/17/20 je FDA Approves Remdesivir
December 17, 2020

From: "Jonathan Edwards" <jonathan.edwards@hhsys.org>
To: "Maggee Kyle" <maggee.kyle@hhsys.org>, "Patrick Newman" <patrick.newman@hhsys.org>, "Berkley Sykes" <berkley.sykes@hhsys.org>, "Eric Franks Pharmacy" <eric.franks@hhsys.org>, "Katie Vandiver" <katie.vandiver@hhsys.org>, "Joseph Ho" <joseph.ho@hhsys.org>, "Christopher Strickland" <christopher.strickland@hhsys.org>, "Donna Huggins" <donna.huggins@hhsys.org>
Cc: "Gregg Knowles" <gregg.knowles@hhsys.org>, "David Collette" <david.collette@hhsys.org>, "Richard Cramer" <richard.cramer@hhsys.org>, "Adam Sawyer" <adam.sawyer@hhsys.org>, "Madeline Belk" <madeline.belk@hhsys.org>
Sent: Thursday, December 17, 2020 10:23:50 AM
Subject: Re: FDA Approves Remdesivir

Group,
 
Remdesivir is now officially an FDA approved, formulary product for adults and pediatric patients with the following exceptions: pediatric patients weighing 3.5 kg to less than 40 kg or pediatric patients less than 12 years of age weighing at least 3.5 kg.  These patients are not included in the FDA approval and are still under the EUA.  
 
We can now stop sending the Fact sheet for all patients that are not included in the exclusions listed above.
 
Please let me know if you have any questions.






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved